# R5P (Riboflavin-5-Phosphate)

> R5P is the activated form of vitamin B2 that bypasses the conversion step plain riboflavin requires. Around 85% of hEDS patients carry MTHFR variants where R5P is the cofactor needed for proper methylation. Riboflavin also has strong evidence in migraine prophylaxis, relevant for the 65% of POTS patients who get migraines. ZebraThrive uses 25 mg AM.

**Page:** https://www.wellnessforzebras.com/ingredients/r5p
**Brand:** ZebraThrive
**Author:** Ken Chapman, Founder of ZebraThrive
**Last reviewed:** 2026-05-11
**Daily dose:** 25 mg AM
**Form used:** Riboflavin-5-Phosphate (R5P), USP grade, 25 mg AM
**Target population:** Adults 18+ with hypermobile Ehlers-Danlos Syndrome (hEDS), Postural Orthostatic Tachycardia Syndrome (POTS), or Mast Cell Activation Syndrome (MCAS).
**Regulatory framing:** US DSHEA dietary supplement. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

## Key benefits

- Activated FAD/FMN cofactor; bypasses the conversion step plain riboflavin requires
- MTHFR-cofactor: keeps methylation working in the ~85% of hEDS patients with MTHFR variants
- Mitochondrial energy: cofactor for Complex I and Complex II of the electron transport chain
- Daily B2 coverage at MTHFR-friendly 25 mg (well below the 400 mg used for migraine prophylaxis)

## What it is

R5P is the activated form of vitamin B2 (riboflavin) - your body normally has to convert plain riboflavin into R5P before it can do its work as a cofactor.

## Why we include it

For people with MTHFR polymorphisms (around 85% of hEDS patients carry at least one variant), R5P is especially important because it's the cofactor MTHFR needs to do methylation properly. Riboflavin has decades of clinical evidence in migraine prophylaxis (relevant because around 65% of POTS patients also have migraines) and supports mitochondrial energy production through the electron transport chain.

## Plain-language summary

R5P is the activated form of vitamin B2 (riboflavin) - your body normally has to convert plain riboflavin into R5P before it can do its work as a cofactor. For people with MTHFR polymorphisms (around 85% of hEDS patients carry at least one variant), R5P is especially important because it's the cofactor MTHFR needs to do methylation properly. Riboflavin has decades of clinical evidence in migraine prophylaxis (relevant because around 65% of POTS patients also have migraines) and supports mitochondrial energy production through the electron transport chain. We use the activated form because the conversion step can be impaired.

## Mechanism

R5P is the activated form of vitamin B2 (riboflavin) - your body normally has to convert plain riboflavin into R5P before it can do its work as a cofactor. For people with MTHFR polymorphisms (around 85% of hEDS patients carry at least one variant), R5P is especially important because it's the cofactor MTHFR needs to do methylation properly. Riboflavin has decades of clinical evidence in migraine prophylaxis (relevant because around 65% of POTS patients also have migraines) and supports mitochondrial energy production through the electron transport chain. We use the activated form because the conversion step can be impaired.

## Condition-specific notes

### MCAS (Mast Cell Activation Syndrome)

R5P doesn't directly engage mast cells - it's a vitamin B2 cofactor. The MCAS-relevant role is indirect and important: methylation. Your body breaks down histamine through HNMT (histamine N-methyltransferase), which needs methyl groups from SAMe, which needs the methyl-folate cycle, which needs MTHFR, which needs R5P. So R5P keeps the histamine clearance pathway functional from the back end. For MCAS patients with MTHFR variants - and most have them - R5P is part of why the methylation support stack (methylfolate, methylated B12, R5P) actually works together. Foundational, not a hero ingredient.

### hEDS (hypermobile Ehlers-Danlos Syndrome)

For hEDS, R5P contributes on two layers. First, mitochondrial energy: riboflavin is the precursor to FAD and FMN, the cofactors for Complex I and Complex II of the electron transport chain. Fibroblasts with mitochondrial dysfunction upregulate MMP-1 (the matrix-degrading enzyme), and supporting energy production at the cellular level helps keep that pathway quieter. Second, methylation: 85% of hEDS patients carry MTHFR variants, and R5P is the cofactor MTHFR needs to do its job. Better methylation supports the whole downstream pathway - neurotransmitters, histamine, homocysteine handling, methyl group availability.

### POTS (Postural Orthostatic Tachycardia Syndrome)

For POTS, R5P has two relevant angles. The first is mitochondrial energy support for the deep fatigue that frequently shadows POTS - many POTS patients also meet ME/CFS criteria. The second is migraine: around 65% of POTS patients also live with migraines, and riboflavin has the strongest clinical data of any nutrient for migraine prophylaxis. Our 25 mg dose is well below the 400 mg used in migraine trials, but it provides daily baseline support. For methylation-related autonomic effects (catecholamine breakdown depends on methylation), R5P plays a quiet but important supporting role.

## Why this form

**Selected form:** Riboflavin-5-Phosphate (R5P), USP grade, 25 mg AM

We use riboflavin-5-phosphate (R5P) - the activated form your enzymes can use directly. Plain riboflavin needs to be converted by riboflavin kinase in your liver before it becomes biologically active, and that conversion step can be impaired in people with chronic illness, inflammation, or methylation pathway dysfunction. Using R5P directly bypasses the conversion bottleneck. The dose is 25 mg - well above the basic vitamin requirement but conservative compared to the 400 mg used in migraine prophylaxis trials. It's an MTHFR-friendly dose for daily methylation support without crossing into therapeutic migraine territory.

## Evidence summary

### MTHFR Cofactor Support and Blood Pressure

Riboflavin (as FAD) is the cofactor for MTHFR. In people with MTHFR C677T variants (around 85% of hEDS patients carry at least one copy), the enzyme is less stable and more dependent on riboflavin availability. RCT evidence in TT-homozygous adults shows targeted riboflavin supplementation produces clinically meaningful blood-pressure improvements, confirming the genotype-cofactor interaction.

- [2] **Rooney M et al., "Higher levels of dietary B vitamins are associated with better blood pressure in homozygous MTHFR 677TT adults".** Design: Cross-sectional dietary intake analysis stratified by MTHFR C677T genotype. Finding: Higher riboflavin intake associated with significantly lower SBP in TT-genotype adults; effect not observed in CC/CT genotypes (cofactor-dependent interaction). PMID: 32330571.
- [3] **Rooney M et al., "Impact of the MTHFR C677T polymorphism on blood pressure phenotype: results from the JINGO project".** Design: Cross-sectional, 242 adults stratified by genotype. Finding: TT homozygotes had SBP ~5.5 mmHg higher than CC counterparts despite similar nutrient intakes; cofactor inadequacy is mechanism. PMID: 35821207.
- [4] **McAuley E et al., "Riboflavin status, MTHFR genotype and blood pressure".** Design: Narrative + targeted review. Finding: Summarises RCT evidence that riboflavin supplementation in TT homozygotes reduces SBP by 5-13 mmHg; identifies riboflavin as a modifiable factor for the most common genetic cause of hypertension. PMID: 27170501.

### Migraine Prophylaxis (Reference Dose)

Riboflavin has decades of clinical evidence in migraine prophylaxis at the reference dose of 400 mg/day; meta-analytic evidence supports a meaningful reduction in monthly headache days. Our 25 mg dose is well below the migraine-prophylactic range and is positioned as foundational methylation support, not migraine treatment.

- [1] **Chen YS et al., "Effects of vitamin B2 supplementation in adults with migraine: a systematic review and meta-analysis".** Design: Systematic review + meta-analysis of 9 studies, 673 subjects, riboflavin 400 mg/day. Finding: Riboflavin supplementation reduced monthly migraine days and frequency vs placebo; effect size consistent across studies. PMID: 33779525.
- [5] **Pringsheim T et al., "Canadian Headache Society guideline for migraine prophylaxis".** Design: Evidence-graded clinical practice guideline. Finding: Riboflavin given a strong recommendation for migraine prophylaxis based on consistent RCT evidence. PMID: 22683887.
- [6] **Sándor PS et al., "Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial".** Design: Randomized, placebo-controlled trial in episodic migraine. Finding: Comparator trial confirming riboflavin as established migraine prophylactic; situates B2 within the mitochondrial-energy class of preventives. PMID: 15728298.

### Mitochondrial Energy and FAD/FMN Cofactor Role

Riboflavin is the precursor to FAD and FMN, the cofactors for Complex I and Complex II of the electron transport chain and the FAD-dependent flavoproteins of fatty acid beta-oxidation. The mitochondrial mechanism is why riboflavin works for migraine and is mechanistically relevant to the deep fatigue many POTS and hEDS patients experience.

- [6] **Sándor PS et al., "Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial".** Design: RCT placing riboflavin alongside CoQ10 in the mitochondrial-energy class. Finding: Establishes mitochondrial energy support (riboflavin -> FAD/FMN -> Complex I/II) as the mechanistic class for migraine prophylaxis and post-exertional fatigue. PMID: 15728298.

## Safety

**Side effects:** Excellent safety profile. May cause harmless bright yellow urine color (excreted excess riboflavin). No clinically meaningful adverse events at the 25 mg dose; trial doses up to 400 mg/day for migraine prophylaxis have been used safely for 3+ months.

**Interactions:** Methotrexate users should mention any methylated B-vitamin stack to their prescriber, as methylated cofactors can affect methotrexate's antifolate mechanism. Some antiepileptics (phenobarbital, carbamazepine) and tetracycline antibiotics can interact with riboflavin metabolism; mention to your prescriber if you are on any of those. Otherwise, R5P has one of the cleaner interaction profiles among B vitamins.

**Excipients to avoid:** Fermentation-derived sources, Artificial colors, Magnesium stearate

**Excipients that are safe:** HPMC capsules, Rice flour, Cellulose

## Frequently asked questions

### Why R5P instead of regular riboflavin?

Riboflavin needs to be converted by an enzyme called riboflavin kinase before your body can use it as a cofactor. That conversion can be impaired in chronic illness, inflammation, hypothyroidism, or methylation pathway issues - all common in this community. R5P is the already-activated form, so it skips the conversion step and goes directly to work. The bioavailability advantage isn't dramatic for healthy people, but for people whose enzyme systems are running compromised, it's a more reliable path.

### Does R5P help with my migraines?

At our 25 mg dose, the migraine effect would be modest - the riboflavin migraine prophylaxis trials used 400 mg/day (16x higher) for 3 months. At 400 mg, about 59% of patients achieve at least 50% reduction in headache days. If migraine is a major issue, you'd need a higher dose than we provide. Our R5P is dosed for daily methylation and mitochondrial support, with migraine support as a modest secondary benefit rather than a primary intervention.

### Why does MTHFR matter for the riboflavin dose?

MTHFR is the enzyme that converts folate into its active methyl form - what your body actually uses for methylation. R5P (as FAD) is MTHFR's required cofactor. In people with MTHFR C677T variants (about 85% of hEDS patients carry at least one copy), the enzyme is less stable and more dependent on R5P availability to work properly. Daily R5P at 25 mg supports stable MTHFR function, which keeps methylation working, which affects everything from neurotransmitter handling to histamine clearance.

### Will R5P interact with my medications?

R5P doesn't have documented interactions with the standard POTS or MCAS medication stack. It doesn't engage CYP enzymes meaningfully, and at 25 mg the methylation load is small. Some medications used in autoimmune and psychiatric conditions (methotrexate, tetracyclines, anti-malarials) can interact with riboflavin metabolism - if you're on any of those, mention R5P to your prescriber. For most patients, it's one of the cleaner B-vitamin choices alongside standard meds.

## References

[1] Chen YS et al.. (2021). Effects of vitamin B2 supplementation in adults with migraine: a systematic review and meta-analysis. PMID: 33779525. https://pubmed.ncbi.nlm.nih.gov/33779525/
[2] Rooney M et al.. (2020). Higher levels of dietary B vitamins are associated with better blood pressure in homozygous MTHFR 677TT adults. PMID: 32330571. https://pubmed.ncbi.nlm.nih.gov/32330571/
[3] Rooney M et al.. (2022). Impact of the MTHFR C677T polymorphism on blood pressure phenotype: results from the JINGO project. PMID: 35821207. https://pubmed.ncbi.nlm.nih.gov/35821207/
[4] McAuley E et al.. (2016). Riboflavin status, MTHFR genotype and blood pressure. PMID: 27170501. https://pubmed.ncbi.nlm.nih.gov/27170501/
[5] Pringsheim T et al.. (2012). Canadian Headache Society guideline for migraine prophylaxis. PMID: 22683887. https://pubmed.ncbi.nlm.nih.gov/22683887/
[6] Sandor PS et al.. (2005). Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. PMID: 15728298. https://pubmed.ncbi.nlm.nih.gov/15728298/